摘要
Phenylazo benzenesulfonamides were designed and synthesized as β-amyloid (Aβ40) fibril assembly inhibitors, and evaluated for inhibition of Aβ40 aggregation and neurotoxicity using rat cortical neurons. Compound 2 (LB-152) was the most potent compound in this study, and the para-NMe2 group on the end of the phenylazo moiety may play an important role in preventing Aβ40 fibril formation. LB-152 provides a new lead for further development of potential β-amyloid aggregation inhibitors to treat AD.
原文 | 英語 |
---|---|
頁(從 - 到) | 1173-1176 |
頁數 | 4 |
期刊 | Bioorganic and Medicinal Chemistry Letters |
卷 | 14 |
發行號 | 5 |
DOIs | |
出版狀態 | 已發佈 - 3月 8 2004 |
Keywords
- Alzheimer's disease
- Benzenesulfonamide
- beta-Amyloid
- Phenylazo
ASJC Scopus subject areas
- 生物化學
- 分子生物學
- 有機化學
- 藥物發現
- 藥學科學